诺和诺德Novo Nordisk（NVO）2023年企业管理报告「NYSE」（英文版）（32页）.pdf

1、Corporate Governance Report 2023Novo Nordisk A/S Novo Alle 1,2880 Bagsvrd,Denmark CVR no.24256790 Juan Pablo Villaseor lives with obesity and cardiovascular disease.Until recently,Juan struggled with stigma and often blamed himself for not being able to lose weight.Today,he exercises regularly and s

2、pends quality time with his son.1.Introduction 32.Corporate governance recommendations and practices 33.Novo Nordisk governance structure 44.Board of Directors 45.Board committees 56.Executive Management 87.Risk management 88.Internal control 9Appendix 1 Novo Nordisks reporting on the Danish Corpora

3、te Governance Recommendations 11Appendix 2 Novo Nordisks reporting on the Corporate Governance Standards of the New York Stock Exchange 24ContentNovo Nordisk Corporate Governance Report 20232 Corporate Governance Report for the financial year 20231.In Danish“Redegrelse for virksomhedsledelse,jf.rsre

4、gnskabslovens 107 b”.2.The Danish Corporate Governance Recommendations are available at:https:/corporategovernance.dk/gaeldende-anbefalinger-god-selskabsledelse.3.The Corporate Governance Standards as included in the NYSE Listed Company Manual are available at:https:/nyse.wolterskluwer.cloud/listed-

5、company-manual.1.IntroductionThis Corporate Governance Report for the financial year 2023 including appendices(the Report)is prepared pursuant to Section 107 b of the Danish Financial Statements Act1 and forms part of the management review in the statutory Annual Report 2023.The sections“Novo Nordis

6、k governance structure”,“Board of Directors”,“Board committees”(except for the 2023 Board committee reports),“Executive Management”,“Risk manage-ment”and“Internal control”are covered by the independent auditors report in the Annual Report 2023,whereas the section“Corporate governance recommendations